4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-20-007710
Chief Financial Officer sold 375 shares at $4.03 ($1,511)
- Chief Financial Officer acquired 893 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie Chief Financial Officer | 2020-02-06 | Option exercise | +893 | 7,500 | D | ||
| Broadfoot Jill Marie Chief Financial Officer | 2020-02-07 | Sale | −375 | $4.03 | $1,511 | 7,125 | D |
| Derivatives | |||||||
| Broadfoot Jill Marie Chief Financial Officer | 2020-02-05 | Grant or award · Employee Stock Option (right to buy) | +23,359 | 23,359 | D | ||
| Broadfoot Jill Marie Chief Financial Officer | 2020-02-06 | Option exercise · Restricted Stock Unit | −893 | 893 | D | ||
| Open-market sales · 375 sh · avg $4.03 · $1,511 | |||||||
Loading xslF345X03/doc4.xml…